Latest News and Press Releases
Want to stay updated on the latest news?
-
AlphaTON Capital at Consensus Hong Kong: Unveiling the Confidential AI Infrastructure for 1 Billion Users
-
香港, Feb. 11, 2026 (GLOBE NEWSWIRE) -- 全球领先的上市科技公司AlphaTON Capital Corp.(纳斯达克代码:ATON)今日宣布,将于2026年2月11日(星期三)至2月12日(星期四)在亚洲顶级 Web3 盛会香港共识大会(地点:香港会议展览中心)期间,举办一系列公开及闭门活动,致力为超十亿月活跃用户的 Telegram...
-
AlphaTON Capital at Consensus Hong Kong: Unveiling the Confidential AI Infrastructure for 1 Billion Users
-
London, UK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Brittany Kaiser, CEO of AlphaTON Capital (Nasdaq: ATON) and global data-rights activist, will speak on a high-profile panel at SALT London 2025, taking...
-
Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and...
-
Dover, DE, Oct. 25, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its wholly owned oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, today...
-
New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (NASDAQ: ATON) (“AlphaTON” or the “Company”), a specialized digital asset treasury company building the TON ecosystem, today...
-
Geneva, Switzerland , Oct. 22, 2025 (GLOBE NEWSWIRE) -- “1 Billion Players. One Tap to Play.” AlphaTON backs gaming where distribution already lives—inside Telegram—pairing funding, launch support,...
-
Dover, DE, Oct. 22, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp (Nasdaq: ATON) and its oncology-focused subsidiary Tarus Therapeutics, LLC, operating as Cyncado Therapeutics, announce that the...
-
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) today announced that its CEO, Brittany Kaiser, will appear alongside Anthony Scaramucci, Founder of SkyBridge...